Navigation Links
New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits
Date:3/14/2009

could provide additional insights and direction."

There are half a million asthma-related hospitalizations and 217,000 ER visits each year. In the United States, hospital care costs for asthma reached $4.7 billion in 2007.

Study Details

The study included 6,574 adult patients who were prescribed inhaled corticosteroid therapy for asthma in 2006 and had one or more asthma-related hospitalizations or ER visits in the previous 12 months. The study followed these patients over a one-year period and compared those using a statin in conjunction with their asthma therapy to those who were not taking a statin.

The findings suggest that statins have a substantial positive impact on controlling asthma. While the incidence of a recurrent hospitalization or ER visit was 29.4 percent for those patients on a corticosteroid but not on a statin, it dropped to 20.5 percent for those patients taking both a corticosteroid and a statin, nearly a one-third reduction in risk.

This is the first in a series of studies that Medco is planning on asthma treatments. Future studies will examine factors that may be impeding the effectiveness of asthma medications.

"Controlling asthma can present tremendous challenges to patients and their physicians," said Dr. Scott Weiss, one of the study researchers and a Professor at Harvard Medical School. "We've known that even when people are compliant with their medications they can still fall victim to serious asthma attacks. Through our research efforts we hope to uncover the answers to why some people respond well to treatment and others do not. Statins may improve a medication's effectiveness, while factors like genetics and vitamin D deficiency may be impacting the benefits of these medications as well."

Inflammation and Asthma Treatments

Asthma is a chronic respiratory disease caused by i
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... BETHESDA, Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. ... developing DCVax® personalized immune therapies for operable and inoperable solid ... will present at the 7 th Annual Phacilitate Immunotherapy ... NW Bio,s presentation at Phacilitate will take place on January ...
(Date:1/23/2015)... 2015  Pete Rose, baseball,s all-time hits leader, is the new ... Myoflex, Ducere Pharma has announced. "Pete,s a Hall ... have him on board with Myoflex," said Ducere Pharma Chief ... player who is known across all generations. The passion and ...
(Date:1/23/2015)... Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Proxy Statement, Schedule 14A, with the U.S. Securities & Exchange ... shareholders detailing why a "YES" vote to increase the number ... As we reflect upon the 2014 fiscal year that ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Pete Rose bets on Myoflex to relieve aches and pains 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... the leader in centralized expert evaluation of treatments for ... using MedAvante Centralized Ratings in their pivotal Phase 3 ... completion of the patient enrollment phase of their clinical ... qualified MedAvante mental health expert at every visit of ...
... InfraReDx, Inc. , a medical device ... the publication of a case report in Circulation ... core plaque as detected by its LipiScan™ Coronary Imaging ... system to provide a Chemogram™ (map of lipid core ...
Cached Medicine Technology:Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study 2Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study 3InfraReDx Announces Publication of a Case Report in Circulation Highlighting Novel Clinical Finding with LipiScan™ Coronary Imaging System 2
(Date:1/22/2015)... 22, 2015 Carinsurancesavings.biz has released a new ... and dismemberment insurance . , Purchasing an accidental death ... very advantageous. This type of rider provides benefits if the ... be considered a lesser form of life insurance. , ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... 2015 Recently, Weddingshe.com has added many trendy ... announced its highest annual revenues in the past three years. ... glamorous wedding dresses. , According to the sales manager of ... promotions for them in 2015. This point can be reflected ...
(Date:1/22/2015)... Four years since the release of their debut recording Love is ... Avasa & Matthew Love – the duo are pleased to announce ... White Swan Records on February 24, 2015. , THE ROAD offers ... to all of us to walk out of the mire of ...
(Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... New analyses from the Women,s Health Initiative (WHI) confirm that ... healthy postmenopausal women. Researchers report a trend toward an ... of hormone therapy among women who began therapy within 10 ... among women who began hormone therapy more than 10 years ...
... disease activity when added to interferon beta , TUESDAY, ... to standard treatment with interferon beta may reduce multiple ... new study reports. , Previous non-randomized studies found that ... disease activity. , This new phase 2 study ...
... ... 2010 , ... February 16, 2010 -- Aberdeen Group, a Harte-Hanks Company has released a new benchmark ... Telecom Expense Management (TEM) solutions as a strategic foundation and precursor for other ...
... ... all natural food service company manages to grow sales and reduce its ... second year in a row, Service Foods, the largest Home Food service ... after increasing sales. Verus Carbon Neutral once again measured and offset 100% ...
... ... Texas, has contracted with Atlanta-based Premier Anesthesia to manage the anesthesia services for its ... ... hospital in east Texas, has contracted with Atlanta-based Premier Anesthesia to manage the anesthesia ...
... ABBOTT PARK, Ill., Feb. 16 Abbott (NYSE: ... EUR 4.5 billion ( $6.2 billion ) acquisition of ... portfolio of pharmaceutical products and expanding Abbott,s presence in key global ... Abbott expects the acquisition to add approximately $2.9 billion ...
Cached Medicine News:Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 2Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 3Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 4Health News:Added Drug Aids MS Treatment 2Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 2Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 3Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 4Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 5Health News:Service Foods Reduces its Carbon Footprint and Grows Sales 2Health News:Service Foods Reduces its Carbon Footprint and Grows Sales 3Health News:Premier Anesthesia Forges New Partnership with Texas Hospital 2Health News:Abbott Completes Acquisition of Solvay Pharmaceuticals 2Health News:Abbott Completes Acquisition of Solvay Pharmaceuticals 3
... any arm -- simply bend the aluminum forearm ... The cuffs are connected by an aluminum bar ... elbow angle. The central part of the joiner ... elbow joint.,Special attention is paid to the patient ...
... lightweight ankle splint may be used for ... ankle. It is effective in stabilizing ... or after cast removal. The rigid ... excellent side-to-side support. The stays also ...
... is designed to assist ambulation for those ... resulting in drop-foot. The anatomically correct shape ... is fabricated from specially formed orthopedic grade ... and reliability. For a more comfortable individual ...
... The VacoSplint has a rigid shell with ... an immobilized foot/ankle. The VacoSplint is a non-weight ... weight bear he/she should transfer to the STORM ... remove the nylon liner from the STORM and ...
Medicine Products: